Last Price$3.20NASDAQ Previous Close - Last Trade as of 4:00PM ET 5/13/22
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$3.21 (2)
Ask (Size)$4.56 (1)
Day Low / HighN/A - N/A

Omeros Confirms Submission of Briefing Package to FDA Following Narsoplimab Concerns

4:05AM ET 1/20/2022 MT Newswires
Omeros (OMER) said late Wednesday it has submitted a briefing package to the US Food and Drug Administration after the agency raised concerns about narsoplimab in a complete response letter.

The company is seeking approval for narsoplimab as a potential treatment for a fatal disease called hematopoietic stem cell transplant-associated thrombotic microangiopathy.

Omeros said it has also requested for a type A meeting with the FDA to resolve any outstanding items.

Price: 5.19, Change: +0.03, Percent Change: +0.58